JAAOS - 2026-10-01 - Journal Article
Evaluating the Safety of Prescription Sleep Medications in Patients Undergoing Total Knee Arthroplasty: A Propensity Matched Analysis.
Young B, Zhuang T, Fernando N, Manner P, Kamal RN, Hernandez NM
Topics
Key Takeaway
Postoperative prescription sleep medication use after TKA is associated with a 26% increased risk of prosthetic joint dislocation (OR 1.26), 12% increased risk of revision surgery (OR 1.12), and 10% increased risk of falls (OR 1.10) within 90 days.
Summary Depth
Choose how much analysis to show on this article page.
Summary
This study used a national administrative claims database (2011–2022) to evaluate whether prescription sleep medication use within 90 days of primary TKA is associated with increased postoperative complications, using propensity-matched multivariable logistic regression. Standard sleep medications (zolpidem, temazepam, eszopiclone, etc.) were associated with significantly increased 90-day and 365-day rates of revision surgery, falls, distal radius fractures, and ED visits (all P<0.05). Less potent agents (doxepin, ramelteon) did not carry the same risk profile, suggesting a class-dependent effect.
Key Limitation
Claims-based design cannot distinguish whether complications resulted from the medication itself, the underlying sleep disorder driving the prescription, or confounding patient frailty not captured by the Elixhauser index.
Original Abstract
BACKGROUND
Impaired sleep is reported in over 50% of patients after a total knee arthroplasty (TKA). Clinicians often treat postoperative sleep disturbances with medications; however, the risks associated with the use of sleep medications after TKA are not well understood. We assessed the association between sleep medication use after TKA and postoperative complications.
METHODS
Using a national administrative claims database, we identified 101,806 patients undergoing primary TKA from 2011 to 2022 who were taking sleep medications within 90 days after surgery and 509,030 patients who were not, which formed the control group. We further analyzed the effects of standard prescription sleep medications (daridorexant, eszopiclone, lemborexant, suvorexant, temazepam, triazolam, zaleplon, zolpidem) and less potent prescription sleep medications (doxepin, ramelteon). Ninety-day and 365-day outcomes investigated were falls, revision surgery, dislocation, fractures, and emergency department (ED) visits. Multivariable logistic regressions were used to calculate odds ratios, adjusting for age, sex, region, insurance plan, Elixhauser Comorbidity Index, preoperative sleep medication usage, and history of mood and anxiety disorders.
RESULTS
Use of any sleep medication was associated with an increased risk of 90-day prosthetic joint dislocations (OR, 1.26; 95% CI, 1.02 to 1.54; P = 0.031), revision surgery (OR, 1.12; 95% CI, 1.02 to 1.24; P = 0.019), falls (OR, 1.10; 95% CI, 1.03 to 1.18; P = 0.008), and ED visits (OR, 1.12; 95% CI, 1.09 to 1.15; P < 0.001). Standard sleep medication usage was correlated with an increased risk of 90-day and 365-day revision surgery, falls, distal radius fractures, and ED visits ( P < 0.05).
CONCLUSIONS
Use of any prescription sleep medication or only standard sleep medications is associated with increased surgical complications. Additional research is needed to find medications that may be safer for routine postoperative use.